» Articles » PMID: 11037739

Headache Characteristics During the Development of Tolerance to Nitrates: Pathophysiological Implications

Overview
Journal Cephalalgia
Specialties Neurology
Psychiatry
Date 2000 Oct 19
PMID 11037739
Citations 13
Authors
Affiliations
Soon will be listed here.
Abstract

Recent studies suggest that nitric oxide (NO) plays an important role in nitrate-induced headache and in spontaneous migraine attacks. Organic nitrates act as prodrugs for NO and headache is a predominant adverse effect of nitrates but often disappears during continuous treatment. Insight into tolerance to headache could lead to insight into vascular headache mechanisms in general. The specific aim of the present study was therefore to characterize the headache and accompanying symptoms during continuous nitrate administration until a state of tolerance to headache had developed. 5-isosorbide-mononitrate (5-ISMN) 30 mg three times daily was administered orally for 7 days in 11 healthy subjects in a double-blind, randomized placebo controlled cross-over design. Wash-out between periods was 14 days or more. Haemodynamic data from the present study were compared to the observed changes of headache over time. Headache during 5-ISMN was longer lasting and more severe compared to placebo (P<0.004). In 10 subjects the headache fulfilled the pain sub-criteria for migraine and in five subjects all diagnostic criteria for migraine without aura were fulfilled. Conversely, 20 min of intravenous infusion of glyceryl trinitrate caused a milder headache and no migraine. The present results therefore suggest that NO may elicit a migraine attack in many healthy subjects if a high enough dose is given for several hours. A close temporal association between the disappearance of headache and the attenuation of the 5-ISMN induced dilatation of the superficial temporal artery was observed. In contrast, tolerance in the middle cerebral artery already appeared after 24 h, which was earlier than the development of tolerance to headache. If vasodilatation is the cause of headache the results point to extracerebral arteries. However, cytotoxic and pain modulating central nervous system effects of NO, the time courses of which are unknown, may also play a role, involving both intra- and extracranial arteries.

Citing Articles

Provocation of attacks to discover migraine signaling mechanisms and new drug targets: early history and future perspectives - a narrative review.

Olesen J J Headache Pain. 2024; 25(1):105.

PMID: 38902612 PMC: 11188241. DOI: 10.1186/s10194-024-01796-1.


Angina in 2022: Current Perspectives.

Manfredi R, Verdoia M, Compagnucci P, Barbarossa A, Stronati G, Casella M J Clin Med. 2022; 11(23).

PMID: 36498466 PMC: 9737178. DOI: 10.3390/jcm11236891.


Headache provocation by nitric oxide in men who have never experienced a headache.

Olofsson I, Falkenberg K, Olesen J, Hansen T Cephalalgia. 2021; 42(7):598-607.

PMID: 34875880 PMC: 9109242. DOI: 10.1177/03331024211060002.


Relationship between nitrate headache and outcome in patients with acute stroke: results from the efficacy of nitric oxide in stroke (ENOS) trial.

Beishon L, Woodhouse L, Bereczki D, Christensen H, Collins R, Gommans J Stroke Vasc Neurol. 2020; 6(2):180-186.

PMID: 33154177 PMC: 8258084. DOI: 10.1136/svn-2020-000498.


Chronic Pain in Chronic Heart Failure: A Review Article.

Alemzadeh-Ansari M, Ansari-Ramandi M, Naderi N J Tehran Heart Cent. 2017; 12(2):49-56.

PMID: 28828019 PMC: 5558055.